Arterial Chemoembolization for the Treatment of Desmoid Fibromatosis

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2028

Conditions
Desmoid
Interventions
PROCEDURE

Chemoembolization with Doxorubicin

"* Identification of the main vessels afferent to the metastasis to be treated.~* Selective and super-selective catheterization of pathological arterial branches, responsible for the blood supply to the neoplasm, through the use of micro-catheters.~* Injection of embolizing material (hydrogel microspheres with doxorubicin)~* Control of technical success: the embolization will be followed by diagnostic arteriography that will evaluate the success of the procedure (occlusion of more than 90 percent of the pathologic vasculature)."

Trial Locations (1)

40136

RECRUITING

Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER